Histogen Inc reports results for the quarter ended in June - Earnings Summary

Histogen

11/08/2022 22:58

* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of
$1.55​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of
$1.70 per share.
    * Revenue held steady 0% to $5.00 thousand from a year ago;
analysts expected zero. 
    * Histogen Inc's reported EPS for the quarter was a loss of
$1.55​.
    * The mean earnings estimate of analysts had fallen by
about 6.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Histogen Inc shares had fallen by 1.8% this quarter and
lost 66.3% so far this year.
    * The company reported a quarterly loss of $3.88 million.
    * Wall Street's median 12-month price target for Histogen
Inc is
$45.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 09:58 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -1.70          -1.55          Beat
 Mar. 31 2022      -1.50          -0.20          Beat
 Dec. 31 2021      -2.10          -1.40          Beat
 Sep. 30 2021      -2.30          -1.80          Beat